Kyle Blankenship, the managing editor of biopharmaceutical news outlet Endpoints News, is leaving for a non-journalism job.
His last day is Friday.
Blankenship has been at Endpoints since December 2020, first as a senior editor. He has been managing editor since February 2021.
He previously worked as an associate editor at FiercePharma, as a city editor and investigations reporter at the Killeen Daily Herald in Texas and as a copy editor of the Bryan-College Station Eagle, also in Texas.
Blankenship holds a master’s degree from the University of North Texas and a bachelor’s degree from Texas A&M University.